Pulse Biosciences Stock: Signs Of Life Following Q1 Update
Luis Alvarez Pulse Biosciences, Inc. (NASDAQ:PLSE) continues to move forward with its pipeline of nanosecond pulsed field ablation (nsPFA) devices. The good news is that the company has received an FDA clearance for its CellFX nsPFA percutaneous electrode …